AAAAAA

   
Results: 1-8 |
Results: 8

Authors: COUDERC B ZITVOGEL L DOUINECHINARD V DJENNANE L TAHARA H FAVRE G LOTZE MT ROBBINS PD
Citation: B. Couderc et al., ENHANCEMENT OF ANTITUMOR IMMUNITY BY EXPRESSION OF CD70 (CD27 LIGAND)OR CD154 (CD40 LIGAND) COSTIMULATORY MOLECULES IN TUMOR-CELLS, Cancer gene therapy, 5(3), 1998, pp. 163-175

Authors: DOUINECHINARD V ROBBINS PD LOTZE MT FAVRE G COUDERC B
Citation: V. Douinechinard et al., ENHANCEMENT OF ANTITUMOR IMMUNITY BY INJECTION OF FIBROBLASTS GENETICALLY-ENGINEERED TO PRODUCE IL-12 AND TO EXPRESS 2 COSTIMULATORY MOLECULES CD70 AND CD80, Cancer gene therapy, 4(5), 1997, pp. 320-320

Authors: LOTZE MT TAHARA H STORKUS WJ SUZUKI T CAI Q COUDERC B ZITVOGEL L
Citation: Mt. Lotze et al., CYTOKINE GENE-THERAPY OF CANCER, Cancer gene therapy, 4(1), 1997, pp. 68-68

Authors: COHENJONATHAN E TOULAS C MONTEIL S COUDERC B MARET A BARD JJ PRATS H DALYSCHVEITZER N FAVRE G
Citation: E. Cohenjonathan et al., RADIORESISTANCE INDUCED BY THE HIGH-MOLECULAR FORMS OF THE BASIC FIBROBLAST GROWTH-FACTOR IS ASSOCIATED WITH AN INCREASED G(2) DELAY AND A HYPERPHOSPHORYLATION OF P34(CDC2) IN HELA-CELLS, Cancer research, 57(7), 1997, pp. 1364-1370

Authors: SERONIEVIVIEN S PRADINES A COUDERC B CLAMAGIRAND C BERG D SOULA G FAVRE G
Citation: S. Seronievivien et al., REVERSION OF TRANSFORMED PHENOTYPE OF HUMAN ADENOCARCINOMA A549 CELLSBY EXPRESSION OF 3-HYDROXY-3-METHYLGLUTARYL COENZYME-A REDUCTASE COMPLEMENTARY-DNA, Cell growth & differentiation, 6(11), 1995, pp. 1415-1425

Authors: AMALRIC F GALY B COUDERC B MARET A PRATS AC PRATS H
Citation: F. Amalric et al., EXPRESSION OF HUMAN FIBROBLAST GROWTH FACTOR-II AND CELL-TRANSFORMATION - SOME PARADOXICAL ASPECTS, Antibody immunoconjugates, and radiopharmaceuticals, 8(4), 1995, pp. 243-250

Authors: COUDERC B DUFYBARBE L SARTOR P
Citation: B. Couderc et al., TERM EFFECTS OF CALCIUM AVAILABILITY ON PROLACTIN AND PROTEIN-SYNTHESIS IN HUMAN DECIDUAL CELLS, Placenta, 16(6), 1995, pp. 527-537

Authors: SERONIEVIVIEN S COUDERC B SOULA G FAVRE G
Citation: S. Seronievivien et al., THE HMGCOA REDUCTASE-DNAC EXPRESSION INHI BITS THE TUMORAL PHENOTYPE OF A549 AND MCF7 HUMAN ADENOCARCINOMA CELLS, Bulletin du cancer, 81(11), 1994, pp. 962-963
Risultati: 1-8 |